Trump administration will fund new research on controversial psychedelic drug ibogaine
Federal officials say there's new funding to study the medical potential of a powerful psychedelic
Covered by 4 sources from 2 countries. First reported by The Independent ·
Headlines compared
Common ground: most headlines mention “Trump administration”, “research”, “controversial psychedelic drug ibogaine” and “fund”.
Different angles:
- PBS NewsHour “officials announce”
- STAT “STAT HHS plans”
How 4 newspapers cover this story
Trump administration will fund new research on controversial psychedelic drug ibogaine
Federal officials say there's new funding to study the medical potential of a powerful psychedelic
· Trump team funds controversial psychedelic ibogaine for veteran PTSD study
Trump administration will fund new research on controversial psychedelic drug ibogaine
Federal officials say there's new funding to study the medical potential of a powerful psychedelic
WATCH: Trump administration officials announce PTSD research funding for psychedelic drug ibogaine
Federal officials on Thursday announced new funding to explore the medical potential of ibogaine, a controversial psychedelic drug championed by veterans, conservative lawmakers and podcasters aligned with President Donald Trump.
STAT+: HHS plans funding for research into ibogaine for PTSD
The Trump administration will funnel up to $4.9 million into supporting research into ibogaine, a psychedelic that’s drawn interest as a potential treatment for PTSD and addiction.
Coverage details
4 outlets from 2 countries are covering this story: The Independent, ABC News, PBS NewsHour and STAT. The Independent published it first, on November 12, 2026; the last outlet to join was STAT, 22 hours later.
Key names in the coverage: Trump and PTSD.
By country: United States (3), United Kingdom (1). In total 5 articles have been published, because some outlets updated the story several times.
